Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

6 Stock Charts To Watch: ABUS, ADAP, FLGT, PBYI, RVNC, SELB

By Harry BoxerETFsFeb 06, 2020 02:56AM ET
www.investing.com/analysis/6-stock-charts-to-watch-abus-adap-flgt-pbyi-rvnc-selb-200505065
6 Stock Charts To Watch: ABUS, ADAP, FLGT, PBYI, RVNC, SELB
By Harry Boxer   |  Feb 06, 2020 02:56AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

1. Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma (NASDAQ:ABUS) has had a fantastic run since Oct, going from under a dollar, all the way up to 3 3/4, it consolidated in a 3-wave, corrective pullback flag, and on Wednesday, it popped with a breakaway gap, up 43 cents, or 15.3%, to 3.24, six points off the 3.30 session high, on 1.6 million shares traded. That’s the biggest volume in about two months. Now, let’s see if it will retest 3 3/4, and then 4 1/4. I think the swing targets are 5 1/2 and 6 3/4

2. Adaptimmune Therapeutics plc (ADAP)

Adaptimmune Therapeutics (NASDAQ:ADAP) is a swing trade of ours that we are watching very carefully. It broke out of a coil on Wednesday and ran 46 cents, or 11.39%, to 4.50, after reaching a high of 4.65, on 1.7 million shares traded. The volume increased a little bit but not enough. If it gets through 4.80-.85, then we’re looking at 6 1/4.

3. Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics (NASDAQ:FLGT) also broke out of a coil on Wednesday, and jumped 1.52, or 11%, to 15.42, not far off the session high at 15.50, on 458,587 shares traded. That’s the biggest volume in about two months. It’s awfully solid here, and if it can get through this zone, and then take out 16 1/2, that’s my target. Mid-channel target is around 18 1/2-19.

4. Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology (NASDAQ:PBYI) exploded Wednesday, jumping 3.98 or 38%, to 14.56, after reaching a high of 15.00, on a whopping 23 million shares traded. I’m looking for a test now of about the 17 3/4-18 range, and then we’ll look at 20 going forward.

5. Revance Therapeutics, Inc. (RVNC)

The Revance (NASDAQ:RVNC) broke out of a wedge as well on Wednesday at the top of the channel, gaining another 1.53, or 6.5%, to 25.07, just two cents off the session and 52-week high at 25.09, on 615,691 shares traded. If it accelerates here, I would be looking at 27 next. With resistance overhead, it may see 30.

6. Selecta Biosciences, Inc. (SELB)

Selecta Biosciences (NASDAQ:SELB) popped 76 cents, or 20.8%, to 4.41, after reaching the session and 52-week high of 4.79, on 1.5 million shares traded on Wednesday. On the daily chart, it looks like it may extend to the 6 1/4 range.

Stocks on the long side

Arbutus Biopharma Corporation (ABUS), Adaptimmune Therapeutics plc (ADAP), Anavex Life Sciences Corp. (AVXL), BioXcel Therapeutics, Inc. (BTAI), Clovis Oncology, Inc. (CLVS), Cyclerion Therapeutics, Inc. (CYCN), 3D Systems Corporation (DDD), Fulgent Genetics, Inc. (FLGT), Grayscale Bitcoin Trust (BTC) (GBTC), MasterCraft Boat Holdings, Inc. (MCFT), Mallinckrodt plc (NYSE:MNK), Nautilus, Inc. (NLS), O-I Glass, Inc. (OI), Puma Biotechnology, Inc. (PBYI), Revance Therapeutics, Inc. (RVNC), SmileDirectClub, Inc. (SDC), and Selecta Biosciences, Inc. (SELB).

Watch video here...

6 Stock Charts To Watch: ABUS, ADAP, FLGT, PBYI, RVNC, SELB
 

Related Articles

6 Stock Charts To Watch: ABUS, ADAP, FLGT, PBYI, RVNC, SELB

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
chris sharkey
chris sharkey Jul 24, 2020 11:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great analysis look forward to next week
Mr MARKET
Mr MARKET Jul 24, 2020 9:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks harry
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email